Siemens Venture Capital partner named on CoreLab Partners' board.
Medical imaging company CoreLab Partners, which was created out of the merger of RadPharm and Medifacts International in December, has raised $4.7m from 10 investors, according to its regulatory filing.
Although there is no statement, Andrew Jay, managing partner of Siemens Venture Capital, is named as a director of CoreLab. Other investors include venture capital firms Ampersand Ventures and SV Life Sciences, according to news provider Mass High Tech that first noticed the filing.
